Piper Sandler & Co. Aytu Biopharma, Inc Transaction History
Piper Sandler & Co.
- $50 Million
- Q2 2024
Shares
4 transactions
Others Institutions Holding AYTU
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About AYTU BIOPHARMA, INC
- Ticker AYTU
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 62,432,700
- Market Cap $134M
- Description
- Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...